NYSE : BAX
Baxter International Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 23 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 11.90B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 11.90B |
| Enterprise Value | 18.73B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Nov 27, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 517.35M |
| Shares Outstanding | 517.35M |
| Shares Change (YoY) | +0.44% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 109.09% |
| Float | 514.76M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 11.11 |
| PS Ratio | 1.02 |
| Forward PS | 1.01 |
| PB Ratio | 1.83 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.47 |
| P/OCF Ratio | 7.26 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.61 |
| EV / EBITDA | 10.22 |
| EV / EBIT | 21.33 |
| EV / FCF | 16.47 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.79 |
| Quick Ratio | 1.00 |
| Debt / Equity | 1.36 |
| Debt / EBITDA | 4.52 |
| Debt / FCF | 7.75 |
| Interest Coverage | 2.95 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -9.04% |
| Return on Assets (ROA) | 2.71% |
| Return on Invested Capital (ROIC) | 6.50% |
| Return on Capital Employed (ROCE) | 5.63% |
| Weighted Average Cost of Capital (WACC) | 5.64% |
| Revenue Per Employee | $309,627 |
| Profits Per Employee | -$19,280 |
| Employee Count | 37,500 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 3.25 |
Taxes
| Measure | Value |
|---|
| Income Tax | 432.00M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +2.59% |
| 50-Day Moving Average | 24.58 |
| 200-Day Moving Average | 21.34 |
| Relative Strength Index (RSI) | 37.75 |
| Average Volume (20 Days) | 6,855,972 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 23.77M |
| Short Previous Month | 23.23M |
| Short % of Shares Out | 4.59% |
| Short % of Float | 4.62% |
| Short Ratio (days to cover) | 3.45 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 11.61B |
| Gross Profit | 3.88B |
| Operating Income | 878.00M |
| Pretax Income | -187.00M |
| Net Income | -723.00M |
| EBITDA | 1.83B |
| EBIT | 878.00M |
| Loss Per Share | -$1.40 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.98B |
| Total Debt | 8.81B |
| Net Cash | -6.83B |
| Net Cash Per Share | -$13.21 |
| Equity (Book Value) | 6.48B |
| Book Value Per Share | 12.57 |
| Working Capital | 3.02B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.64B |
| Capital Expenditures | -503.00M |
| Depreciation & Amortization | 955.00M |
| Net Borrowing | -586.00M |
| Free Cash Flow | 1.14B |
| FCF Per Share | $2.20 |
Margins
| Measure | Value |
|---|
| Gross Margin | 33.37% |
| Operating Margin | 7.56% |
| Pretax Margin | -1.61% |
| Profit Margin | -6.23% |
| EBITDA Margin | 15.79% |
| EBIT Margin | 7.56% |
| FCF Margin | 9.79% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.04 |
| Dividend Yield | 0.17% |
| Dividend Growth (YoY) | -92.31% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 1.82% |
| Buyback Yield | -0.44% |
| Shareholder Yield | -0.27% |
| Earnings Yield | -6.10% |
| FCF Yield | 9.56% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $27.08 |
| Price Target Difference | 17.74% |
| Analyst Consensus | Hold |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 2.68% |
| EPS Growth Forecast (3Y) | -1.34% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 31, 2001 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.44 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |